Correlation Between Nabriva Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nabriva Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nabriva Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nabriva Therapeutics AG and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Nabriva Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nabriva Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nabriva Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Nabriva Therapeutics and Pieris Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nabriva and Pieris is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Nabriva Therapeutics AG and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Nabriva Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nabriva Therapeutics AG are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Nabriva Therapeutics i.e., Nabriva Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nabriva Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Nabriva Therapeutics AG is expected to generate 0.82 times more return on investment than Pieris Pharmaceuticals. However, Nabriva Therapeutics AG is 1.22 times less risky than Pieris Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 196.00 in Nabriva Therapeutics AG on August 29, 2024 and sell it today you would lose (34.00) from holding Nabriva Therapeutics AG or give up 17.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.31% |
| Values | Daily Returns |
Nabriva Therapeutics AG vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Pieris Pharmaceuticals |
Nabriva Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nabriva Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Nabriva Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nabriva Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.The idea behind Nabriva Therapeutics AG and Pieris Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets |